Name Description
aflibercept consists of the second and third Ig domains of VEGFR1 and VEGFR2, respectively, fusion to the Fc region of IgG1; putative antineoplastic agent that binds all VEGF-A isoforms; possible medicine for eye disorders
TCRDv4.6.0
DisGeNET
GWASCAT
DrugCentral Indication
DrugCentral
aflibercept